Thiazolidinediones (TZDs) is types of insulin sensitizing drugs used for type 2 diabetes treatments and it ameliorate insulin resistance by promoting the adipocyte proliferation and differentiation through up-regulation of PPAR-γ in the adipocyte. Here, PPARG is linked to type 2 diabetes mellitus.